| 2019-12-13 13:18:25|
AMRN 13:18 12/13 12/13/19
Amarin halts for news two weeks ahead of FDA action date
Shares of Amarin halted for news pending this afternoon, two weeks ahead of the December 28 FDA action date on the company's proposed label expansion for Vascepa. The shares halted up 5%, or $1.13, to $24.12.
See Street Research during your Free Trial